EGFR and lung carcinoma: This study is the first to report the significant cytotoxic effect of panduratin A on the H1975 lung cancer cell line, an established model bearing the T790M mutation in addition to the L858R mutation, which is commonly used to study acquired resistance to EGFR-TKIs [46,47].